AlphaNavi Pharma Inc.
PrivateLast Round
Series B
Mar 1, 2023
Total Funding Raised
$12.66M
Company Overview
AlphaNavi Pharma Inc. is a biopharmaceutical company that develops novel analgesic drugs for patients suffering from pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlphaNavi Pharma Inc. Comparables
Compare AlphaNavi Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 82% | |
| Guangzhou Fermion Technology Co., Ltd. | 82% | |
| Latigo Biotherapeutics | 76% |
AlphaNavi Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2023 | ||||
| Series A | Mar 28, 2019 |
Key People
Founding team and executive leadership
AlphaNavi Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series A, Series B |
| Shinsei Capital Partners | Series A, Series B |
| 日本ベンチャーキャピタル株式会社 | Series A, Series B |
| Kyoto University Innovation Capital | Series A, Series B |
| SMBC Venture Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Monthly visitors grew 91% MoM.
- Jul 6, 2025
Monthly visitors increased 38% MoM.
AlphaNavi Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access